ExpressionEdits
ExpressionEdits is a biotechnology company that redefines protein expression by focusing on the precise use of genetic grammar in transgenic design. Their core technology, the Genetic Syntax Engine, is an AI-driven computational platform that optimizes genetic instructions, particularly through a proprietary intronization process. This allows for the production of proteins previously considered beyond reach and overcomes limitations of conventional methods. The company is developing an internal pipeline of high-value protein therapeutics and is seeking external partnerships, especially in gene therapy, to boost potency and precision. They have secured $13M in seed funding and have appointed Dr. Amrik Basran as Chief Scientific Officer and Dr. Paul Bolno as Chair of the Board of Directors.
ExpressionEdits
ExpressionEdits is a biotechnology company that redefines protein expression by focusing on the precise use of genetic grammar in transgenic design. Their core technology, the Genetic Syntax Engine, is an AI-driven computational platform that optimizes genetic instructions, particularly through a proprietary intronization process. This allows for the production of proteins previously considered beyond reach and overcomes limitations of conventional methods. The company is developing an internal pipeline of high-value protein therapeutics and is seeking external partnerships, especially in gene therapy, to boost potency and precision. They have secured $13M in seed funding and have appointed Dr. Amrik Basran as Chief Scientific Officer and Dr. Paul Bolno as Chair of the Board of Directors.